相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Fibroblast growth factor 15/19 expression, regulation, and function: An overview
Greg Guthrie et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2022)
Mineralocorticoid Receptor Antagonism Prevents the Synergistic Effect of Metabolic Challenge and Chronic Kidney Disease on Renal Fibrosis and Inflammation in Mice
Roberto Palacios-Ramirez et al.
FRONTIERS IN PHYSIOLOGY (2022)
Impaired muscle mitochondrial energetics is associated with uremic metabolite accumulation in chronic kidney disease
Trace Thome et al.
JCI INSIGHT (2021)
FGF19 protects skeletal muscle against obesity-induced muscle atrophy, metabolic derangement and abnormal irisin levels via the AMPK/SIRT-1/PGC-α pathway
Ai Guo et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2021)
The role of farnesoid X receptor in metabolic diseases, and gastrointestinal and liver cancer
Lulu Sun et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2021)
A low aromatic amino-acid diet improves renal function and prevent kidney fibrosis in mice with chronic kidney disease
Christophe Barba et al.
SCIENTIFIC REPORTS (2021)
Fibroblast growth factor 19 as a countermeasure to muscle and locomotion dysfunctions in experimental cerebral palsy
Sabrina da Conceicao Pereira et al.
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2021)
Intestinal-derived FGF15 protects against deleterious effects of vertical sleeve gastrectomy in mice
Nadejda Bozadjieva-Kramer et al.
NATURE COMMUNICATIONS (2021)
Fibroblast Growth Factor 19-Mediated Up-regulation of SYR-Related High-Mobility Group Box 18 Promotes Hepatocellular Carcinoma Metastasis by Transactivating Fibroblast Growth Factor Receptor 4 and Fms-Related Tyrosine Kinase 4
Jie Chen et al.
HEPATOLOGY (2020)
Serum Endocrine Fibroblast Growth Factors as Potential Biomarkers for Chronic Kidney Disease and Various Metabolic Dysfunctions in Aged Patients
Shogo Yamamoto et al.
INTERNAL MEDICINE (2020)
Muscle-derived interleukin 6 increases exercise capacity by signaling in osteoblasts
Subrata Chowdhury et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
Accumulation of natriuretic peptides is associated with protein energy wasting and activation of browning in white adipose tissue in chronic kidney disease
Mathilde Luce et al.
KIDNEY INTERNATIONAL (2020)
Contribution of uremic dysbiosis to insulin resistance and sarcopenia
Kiyotaka Uchiyama et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2020)
Curtailing FGF19's mitogenicity by suppressing its receptor dimerization ability
Jianlou Niu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Deletion of OPN in BSP knockout mice does not correct bone hypomineralization but results in high bone turnover
W. Bouleftour et al.
BONE (2019)
Chronic kidney disease and aging differentially diminish bone material and microarchitecture in C57Bl/6 mice
Chelsea M. Heveran et al.
BONE (2019)
Effect of skeletal muscle phenotype and gender on fasting-induced myokine expression in mice
Wei-hua Jia et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2019)
Chronic kidney disease exacerbates ischemic limb myopathy in mice via altered mitochondria! energetics
Fabian N. Berru et al.
SCIENTIFIC REPORTS (2019)
The Klotho proteins in health and disease
Makoto Kuro-o
NATURE REVIEWS NEPHROLOGY (2019)
Chronic Kidney Disease Is Associated with Increased Plasma Levels of Fibroblast Growth Factors 19 and 21
Malgorzata Marchelek-Mysliwiec et al.
KIDNEY & BLOOD PRESSURE RESEARCH (2019)
Higher blood urea nitrogen is associated with increased risk of incident diabetes mellitus
Yan Xie et al.
KIDNEY INTERNATIONAL (2018)
NGM282 for treatment of non-alcoholic steatohepatitis: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial
Stephen A. Harrison et al.
LANCET (2018)
Factors Related to Osteosarcopenia in Kidney Transplant Recipients
M. Yanishi et al.
TRANSPLANTATION PROCEEDINGS (2018)
Fibroblast growth factor 19 regulates skeletal muscle mass and ameliorates muscle wasting in mice
Berengere Benoit et al.
NATURE MEDICINE (2017)
FGF19, FGF21, and an FGFR1/β-Klotho-Activating Antibody Act on the Nervous System to Regulate Body Weight and Glycemia
Tian Lan et al.
CELL METABOLISM (2017)
Engineered Fibroblast Growth Factor 19 Reduces Liver Injury and Resolves Sclerosing Cholangitis in Mdr2-Deficient Mice
Mei Zhou et al.
HEPATOLOGY (2016)
Therapeutic potential of the endocrine fibroblast growth factors FGF19, FGF21 and FGF23
Chiara Degirolamo et al.
NATURE REVIEWS DRUG DISCOVERY (2016)
Muscle wasting in end-stage renal disease promulgates premature death: established, emerging and potential novel treatment strategies
Peter Stenvinkel et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2016)
Urea impairs β cell glycolysis and insulin secretion in chronic kidney disease
Laetitia Koppe et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
Probiotics and chronic kidney disease
Laetitia Koppe et al.
KIDNEY INTERNATIONAL (2015)
A Pegylated Leptin Antagonist Ameliorates CKD-Associated Cachexia in Mice
Wai W. Cheung et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2014)
Chronic kidney disease reduces muscle mitochondria and exercise endurance and its exacerbation by dietary protein through inactivation of pyruvate dehydrogenase
Masanori Tamaki et al.
KIDNEY INTERNATIONAL (2014)
Mechanisms of muscle wasting in chronic kidney disease
Xiaonan H. Wang et al.
NATURE REVIEWS NEPHROLOGY (2014)
Elevated hepatic 11β-hydroxysteroid dehydrogenase type 1 induces insulin resistance in uremia
Ananda Chapagain et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Effect of chronic renal failure on the hepatic, intestinal, and renal expression of bile acid transporters
Zhibo Gai et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2014)
Stat3 Activation Links a C/EBPδ to Myostatin Pathway to Stimulate Loss of Muscle Mass
Liping Zhang et al.
CELL METABOLISM (2013)
p-Cresyl Sulfate Promotes Insulin Resistance Associated with CKD
Laetitia Koppe et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2013)
Impaired postprandial fibroblast growth factor (FGF)-19 response in patients with stage 5 chronic kidney diseases is ameliorated following antioxidative therapy
Meng Li et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2013)
Metabolic and morphometric profile of muscle fibers in chronic hemodialysis patients
Michael I. Lewis et al.
JOURNAL OF APPLIED PHYSIOLOGY (2012)
Decreased renal α-Klotho expression in early diabetic nephropathy in humans and mice and its possible role in urinary calcium excretion
Osamu Asai et al.
KIDNEY INTERNATIONAL (2012)
Muscles, exercise and obesity: skeletal muscle as a secretory organ
Bente K. Pedersen et al.
NATURE REVIEWS ENDOCRINOLOGY (2012)
Pharmacological inhibition of myostatin suppresses systemic inflammation and muscle atrophy in mice with chronic kidney disease
Liping Zhang et al.
FASEB JOURNAL (2011)
OPPORTUNITY™: a large-scale randomized clinical trial of growth hormone in hemodialysis patients
Joel D. Kopple et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2011)
FGF19 as a Postprandial, Insulin-Independent Activator of Hepatic Protein and Glycogen Synthesis
Serkan Kir et al.
SCIENCE (2011)
Fibroblast Growth Factor 19 Serum Levels: Relation to Renal Function and Metabolic Parameters
M. Reiche et al.
HORMONE AND METABOLIC RESEARCH (2010)
Frailty and Chronic Kidney Disease: The Third National Health and Nutrition Evaluation Survey
Emilee R. Wilhelm-Leen et al.
AMERICAN JOURNAL OF MEDICINE (2009)
Beyond FRAX (R): It's Time to Consider Sarco-Osteopenia
Neil Binkley et al.
JOURNAL OF CLINICAL DENSITOMETRY (2009)
Chronic kidney disease causes defects in signaling through the insulin receptor sub strate/phosphatidylinositol 3-kinase/Akt pathway: Implications for muscle atrophy
James L. Bailey et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2006)
Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis
T Inagaki et al.
CELL METABOLISM (2005)
Fibroblast growth factor 19 increases metabolic rate I and reverses dietary and leptlin-deficient diabetes
L Fu et al.
ENDOCRINOLOGY (2004)
Effects of body size and body composition on survival in hemodialysis patients
S Beddhu et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2003)
分享论文
